Cargando…
Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?
Recent studies in various rodent models of pathologic ventricular hypertrophy report the re-expression of deiodinase type 3 (D3) in cardiomyocytes. D3 inactivates thyroid hormone (T3) and is mainly expressed in tissues during development. The stimulation of D3 activity in ventricular hypertrophy and...
Autores principales: | Pol, Christine J., Muller, Alice, Simonides, Warner S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820687/ https://www.ncbi.nlm.nih.gov/pubmed/19107595 http://dx.doi.org/10.1007/s10741-008-9133-7 |
Ejemplares similares
-
Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling
por: Janssen, Rob, et al.
Publicado: (2014) -
Divergent Thyroid Hormone Levels in Plasma and Left Ventricle of the Heart in Compensated and Decompensated Cardiac Hypertrophy Induced by Chronic Adrenergic Stimulation in Mice
por: Simonides, Warner, et al.
Publicado: (2023) -
MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III
por: Janssen, Rob, et al.
Publicado: (2016) -
Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story
por: Elnakish, Mohammad T., et al.
Publicado: (2015) -
Cardiac hypertrophy and thyroid hormone signaling
por: Dillmann, Wolfgang
Publicado: (2009)